Active

Deraphar

Switched

BE0439109003

Rechtspersoon Private limited company 1 establishment

Grote Markt 44, 9060 Zelzate Apothekers

Active for

36 year, 9 months

Financials

Financial year 2025

Gross margin

€ 104,127

▼ 46% vs 2024

Profit

Caution

€ -88,165

▼ 2592% vs 2024

Debts

Normal

€ 508,783

▲ 2% vs 2024

Deraphar from Zelzate, company number BE0439109003, closed financial year 2025 with a result of € -88,165 after tax. For that financial year Deraphar recorded a gross margin of € 104,127 and equity of € 270,143. Compared with financial year 2024, the result moved from € 3,538 to € -88,165. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What happened at Deraphar?

What happened at Deraphar in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 88,165 (▼ 2592% vs 2024). Source: NBB ↗
  • Decura Pharma became a director. NBB
  • New establishment in Zelzate. KBO
  • Start of the company according to the CBE. KBO

In short

From € 71,200 profit in 2021 to € 88,165 loss in 2025.

Paid € 974 in corporate taxes since 2021.

Best year ever: 2021, with € 71,200 profit.

On average € 54,800 of value added per employee in 2025.

A new publication or filing at Deraphar? We notify you, reason included.

Follow Deraphar

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind Deraphar is Decura Pharma. It owns Zorgpunt itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Decura Pharma

Director · represented by Ann Raes

Also active at: MEDISALE, LINDEPHAR, APOTHEEK RAES +4 more

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Grote Markt 44

9060 Zelzate

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0439.109.003
VAT number
BE 0439.109.003
Registered office
Grote Markt 44, 9060 Zelzate
Names & denominations
Deraphar
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 December 1989
Peppol
Active · Active since 28 Aug 2023
Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of Deraphar?
The enterprise number of Deraphar is BE0439109003.
What is the address of Deraphar?
The registered office of Deraphar is located at Grote Markt 44, 9060 Zelzate.
When was Deraphar founded?
Deraphar was founded on 4 December 1989.
What is the main activity of Deraphar?
The main activity of Deraphar is "Apothekers" (NACE code 52310).
Does Deraphar have a website?
No website is currently known for Deraphar.
How much profit did Deraphar make in 2025?
Deraphar recorded a loss after taxes of € 88,165 in financial year 2025.
What is the revenue of Deraphar?
As a small company, Deraphar is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 104,127.
How many employees does Deraphar have?
According to the 2025 annual accounts, Deraphar has 1.9 full-time equivalents (FTE).
Where can I find the annual accounts of Deraphar?
Deraphar files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Deraphar?
According to the 2025 annual accounts, the directors of Deraphar are: Decura Pharma.
Who owns Deraphar?
Behind Deraphar is Decura Pharma. It owns Zorgpunt itself.